IP Verse

Weinzierl, Gerhard competitive analysis

Explore patent oppositions filed by Weinzierl, Gerhard against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP3351261	Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy	UNIVERSITT ZRICH	Mar 2, 2022
EP3330370	Process For Cultivation Of Cho Cells	NOVARTIS	Nov 23, 2021
EP3062798	Modified Rna With Decreased Immunostimulatory Properties	CUREVAC	Feb 8, 2021
EP3338794	Toxicity Management For Anti-Tumor Activity Of Cars	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Nov 26, 2020
EP3116902	Method For Generating T-Cells Compatible For Allogenic Transplantation	CELLECTIS	Oct 1, 2020
EP1797886	Immune Stimulation Using Chemically Modified Rna	CUREVAC	Apr 9, 2020
EP2337849	Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production	SIMIONI	Mar 12, 2019
EP2563906	Improved Cell Cultivation Process	NOVARTIS	Aug 8, 2018
EP3013849	Purification Process For Monoclonal Antibodies	CADILA HEALTHCARE	Jun 13, 2018
EP2513134	Wash Solution And Method For Affinity Chromatography	NOVARTIS	Jun 6, 2018

Discover the latest PTAB cases involving Weinzierl, Gerhard, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Weinzierl, Gerhard with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
WEINZIERL, GERHARD	10	-	-	-
CELLECTIS	-	21	-	-
CUREVAC	-	68	-	1
NOVARTIS	6	467	-	21